Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Lenvatinib (mesylate) | 857890-39-2 | 99.7% | 522.96 | 25 MG
SDP

Catalog No. 5000347036
Encompass_Preferred

Lenvatinib mesylate is an oral, multi-targeted tyrosine kinase inhibitor. It inhibits vascular endothelial growth factor receptors (VEGFR1-3), fibroblast growth factor receptors (FGFR1-4), platelet-derived growth factor receptor (PDGFR), KIT, and RET. The compound demonstrates potent antitumor activities.

  • Inhibits VEGFR2 with an IC50 of 4 nM
  • Inhibits VEGFR3 with an IC50 of 5.2 nM
  • Inhibits VEGFR1 with an IC50 of 22 nM
  • Inhibits PDGFRα with an IC50 of 51 nM
  • Inhibits PDGFRβ with an IC50 of 39 nM
  • Inhibits FGFR1 with an IC50 of 46 nM
  • Inhibits KIT with an IC50 of 100 nM
  • Significantly inhibits local tumor growth and metastasis in preclinical models

Catalog No. 50-003-47036 Supplier Medchemexpress LLC Supplier No. 25MGHY10981A
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Lenvatinib mesylate is an oral, multi-targeted tyrosine kinase inhibitor. It inhibits vascular endothelial growth factor receptors (VEGFR1-3), fibroblast growth factor receptors (FGFR1-4), platelet-derived growth factor receptor (PDGFR), KIT, and RET. The compound demonstrates potent antitumor activities.

  • Inhibits VEGFR2 with an IC50 of 4 nM
  • Inhibits VEGFR3 with an IC50 of 5.2 nM
  • Inhibits VEGFR1 with an IC50 of 22 nM
  • Inhibits PDGFRα with an IC50 of 51 nM
  • Inhibits PDGFRβ with an IC50 of 39 nM
  • Inhibits FGFR1 with an IC50 of 46 nM
  • Inhibits KIT with an IC50 of 100 nM
  • Significantly inhibits local tumor growth and metastasis in preclinical models

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.